• 3654 Citations
  • 20 h-Index
19972019
If you made any changes in Pure these will be visible here soon.

Research Output 1997 2019

  • 3654 Citations
  • 20 h-Index
  • 55 Article
  • 2 Chapter
  • 1 Comment/debate
  • 1 Review article
Filter
Comment/debate
2018

Correction: Everolimus (Eve) and exemestane (EXE) in patients with advanced breast cancer aged ≥ 65 years: New lessons for clinical practice from the EVA study (Oncotarget (2018) 9:77 (34639-34640) DOI: 10.18632/oncotarget.25874)

Cazzaniga, M., Verusio, C., Ciccarese, M., Fumagalli, A., Sartori, D., Ancona, C., Airoldi, M., Moretti, G., Ficorella, C., Arcangeli, V., Diodati, L., Zambelli, A., Febbraro, A., Generali, D., Pistelli, M., Garrone, O., Musolino, A., Vici, P., Maur, M., Mentuccia, L. & 17 others, La Verde, N., Bianchi, G., Artale, S., Blasi, L., Piezzo, M., Atzori, F., Turletti, A., Benedetto, C., Cursano, M. C., Fabi, A., Gebbia, V., Schirone, A., Palumbo, R., Ferzi, A., Frassoldati, A., Scavelli, C. & Clivio, L., Aug 1 2018, In : Oncotarget. 9, 77, p. 34639-34640 2 p.

Research output: Contribution to journalComment/debate

exemestane
Extravehicular Activity
Names
Breast Neoplasms
Everolimus